Oppenheimer Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,024
Closed -$22K 1521
2019
Q4
$22K Buy
1,024
+133
+15% +$3.05K ﹤0.01% 1443
2019
Q3
$20K Buy
891
+375
+73% +$10.4K ﹤0.01% 1457
2019
Q2
$19K Buy
516
+95
+23% +$3.04K ﹤0.01% 1481
2019
Q1
$13K Sell
421
-73
-15% -$2.13K ﹤0.01% 1479
2018
Q4
$12K Buy
+494
New +$12.7K ﹤0.01% 1498

Other funds holding CDNA

Oppenheimer Asset Management's CDNA Position: Q1 2020 in Review

Oppenheimer Asset Management sold out of CareDx (CDNA) in Q1 2020, closing a stake of 1,024 shares — an estimated $22K sold.

Oppenheimer Asset Management first reported a position in CDNA in Q4 2018 and held it in 5 quarters. The position peaked at $22K in Q4 2019. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.

  • Oppenheimer Asset Management reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 1,024 CareDx shares in Q1 2020, an estimated $22K.
  • Oppenheimer Asset Management first reported a position in CareDx in Q4 2018 and held it in 5 quarters.
  • Oppenheimer Asset Management's CareDx position peaked at $22K in Q4 2019.
  • 144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.

Based on Oppenheimer Asset Management's 13F filing for Q1 2020, filed 8 May 2020.